Peripheral Arterial Disease Management

Risk Factors and Pathophysiology

The American Heart Association suggests that hypertension is a major risk factor for PAD that accelerates atherosclerosis and vascular remodeling 1
Obesity (BMI 31) creates a clustering of cardiovascular risk factors and is strongly associated with hypertension, with 35.7% of obese individuals having hypertension 2
Former smoking history contributes to atherosclerotic burden, and smoking cessation may be the most important factor in whether PAD progresses 1
The combination of obesity with hypertension creates a synergistic effect on cardiovascular risk that exceeds the sum of individual effects 4

The American Academy of Family Physicians recommends performing ankle-brachial index (ABI) testing, as values <0.90 are 95% sensitive and specific for angiographic PAD and strongly associated with walking limitations 5
The American Heart Association suggests that achieving ideal body weight is a core component of PAD medical therapy 1, 7
Weight loss combined with structured exercise programs increases pain-free and maximum walking distances in patients with intermittent claudication 1
The American College of Cardiology recommends blood pressure control, treating hypertension in PAD patients reduces risk of MI, stroke, heart failure, and death 1
Lipid management, with LDL lowering, reduces CVD events in people with PAD (goal LDL <100 mg/dL) 1, 4

A structured walking program increases walking distance despite discomfort and is a cornerstone of PAD therapy 1, 7
Antiplatelet therapy, such as aspirin or clopidogrel, should be administered for cardiovascular protection 1
Obesity management addresses multiple pathophysiological mechanisms, including insulin resistance, inflammation, and endothelial dysfunction 8